Robitussin cough syrup recalled by Haleon in US due to contamination
Robitussin is frequently used to treat respiratory allergies, flu, cold, fever
Robitussin cough syrup supplied nationally is being recalled by Haleon owing to microbial contamination that may cause fatal infections in susceptible individuals, the US division of the global consumer health company based in the UK announced this week.
"Use of the recalled products could potentially result in severe or life-threatening fungal infections in those with impaired immune systems," Haleon stated in a notice posted by the Food and Drug Administration, according to CBS.
"Most users are unlikely to experience a serious health problem, but an infection that requiring medical intervention can't be ruled out," the company said.
Robitussin is frequently used to treat respiratory allergies, the common cold, the flu, and hay fever. The following goods are included in the recall, along with their lot numbers and expiration dates:
Robitussin Honey CF Max Day Adult 4oz — T10810 — October 31, 2025
Robitussin Honey CF Max Day Adult 8oz — T08730, T08731, T08732, T08733 — May 31, 2025
Robitussin Honey CF Max Day Adult 8oz — T10808 — September 30, 2025
Robitussin Honey CF Max NT Adult 8oz — T08740, T08742 — June 30, 2026
"Consumers who purchased the recalled products shouldn't use them," Haleon said.
-
Is teen anger linked to faster aging? Here’s what the study reveals
-
Senate prioritizes Housing as Crypto bill hits new impasse, stalling Trump’s ‘Clarity Act’ agenda
-
Teddi Mellencamp reveals medication side-effects landed her in the hospital
-
Billy Porter claims he came back from the dead amid sepsis battle
-
Childhood obesity crisis: 220 million kids may be affected by 2040, report warns
-
Christopher Reid gives update on his ‘heart failure’
-
South Korea markets sink as Kospi records worst day in decades amid Iran conflict
-
Paris Hilton's power move to make 'neurodiversity relatable'